Quantitative fluorescence determination of long-fragment DNA in stool as a marker for the early detection of colorectal cancer

Daniele Calistri, Claudia Rengucci, Chiara Molinari, Enrico Ricci, Elena Cavargini, Emanuela Scarpi, Gian Luigi Milandri, Carla Fabbri, Alberto Ravaioli, Antonio Russo, Dino Amadori, Rosella Silvestrini

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: A variety of molecular markers have been evaluated for the development of a non-invasive approach to the diagnosis of colorectal cancer. We aimed to validate the diagnostic accuracy, using the same threshold as in the previous pilot study, of fluorescent long DNA test as a relatively simple and inexpensive tool for colorectal cancer detection. Methods: A case-control study was conducted on 100 healthy subjects and 100 patients at first diagnosis of colorectal cancer. Human long-fragment DNA in stool was quantified by fluorescence primers and a standard curve and expressed in DNA nanograms. Results: We validated the 25-ng value, which emerged as the most accurate cut-off in the pilot study, obtaining 79% (95% CI, 71-87%) sensitivity and 89% (95% CI, 83-95%) specificity. Specificity was very high for all cut-off values (15-40 ng) analyzed, ranging from 78 to 96%. Sensitivity was only slightly lower, reaching 84% at the lowest cut-off and maintaining a good level at the higher values. Diagnostic potential was independent of gender, age and tumor site. Conclusion: Fecal DNA analysis is a non-invasive and fairly simple test showing high diagnostic potential. These characteristics, together with the small amount of stool required, make it potentially suitable to be used alongside or as an alternative to current non-invasive screening approaches. Our next step will be to validate these results in a large-scale cohort study of a screening population, which is needed prior to implementation into clinical practice.

Original languageEnglish
Pages (from-to)11-17
Number of pages7
JournalCellular Oncology
Volume31
Issue number1
DOIs
Publication statusPublished - 2009

Fingerprint

Early Detection of Cancer
Colorectal Neoplasms
Fluorescence
DNA
Case-Control Studies
Healthy Volunteers
Cohort Studies
Population
Neoplasms

Keywords

  • Colorectal cancer
  • Diagnosis
  • Fluorescence long DNA
  • Stool

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Molecular Medicine

Cite this

Quantitative fluorescence determination of long-fragment DNA in stool as a marker for the early detection of colorectal cancer. / Calistri, Daniele; Rengucci, Claudia; Molinari, Chiara; Ricci, Enrico; Cavargini, Elena; Scarpi, Emanuela; Milandri, Gian Luigi; Fabbri, Carla; Ravaioli, Alberto; Russo, Antonio; Amadori, Dino; Silvestrini, Rosella.

In: Cellular Oncology, Vol. 31, No. 1, 2009, p. 11-17.

Research output: Contribution to journalArticle

Calistri, Daniele ; Rengucci, Claudia ; Molinari, Chiara ; Ricci, Enrico ; Cavargini, Elena ; Scarpi, Emanuela ; Milandri, Gian Luigi ; Fabbri, Carla ; Ravaioli, Alberto ; Russo, Antonio ; Amadori, Dino ; Silvestrini, Rosella. / Quantitative fluorescence determination of long-fragment DNA in stool as a marker for the early detection of colorectal cancer. In: Cellular Oncology. 2009 ; Vol. 31, No. 1. pp. 11-17.
@article{515510fd4e3d46059993c7069f6d29d3,
title = "Quantitative fluorescence determination of long-fragment DNA in stool as a marker for the early detection of colorectal cancer",
abstract = "Background: A variety of molecular markers have been evaluated for the development of a non-invasive approach to the diagnosis of colorectal cancer. We aimed to validate the diagnostic accuracy, using the same threshold as in the previous pilot study, of fluorescent long DNA test as a relatively simple and inexpensive tool for colorectal cancer detection. Methods: A case-control study was conducted on 100 healthy subjects and 100 patients at first diagnosis of colorectal cancer. Human long-fragment DNA in stool was quantified by fluorescence primers and a standard curve and expressed in DNA nanograms. Results: We validated the 25-ng value, which emerged as the most accurate cut-off in the pilot study, obtaining 79{\%} (95{\%} CI, 71-87{\%}) sensitivity and 89{\%} (95{\%} CI, 83-95{\%}) specificity. Specificity was very high for all cut-off values (15-40 ng) analyzed, ranging from 78 to 96{\%}. Sensitivity was only slightly lower, reaching 84{\%} at the lowest cut-off and maintaining a good level at the higher values. Diagnostic potential was independent of gender, age and tumor site. Conclusion: Fecal DNA analysis is a non-invasive and fairly simple test showing high diagnostic potential. These characteristics, together with the small amount of stool required, make it potentially suitable to be used alongside or as an alternative to current non-invasive screening approaches. Our next step will be to validate these results in a large-scale cohort study of a screening population, which is needed prior to implementation into clinical practice.",
keywords = "Colorectal cancer, Diagnosis, Fluorescence long DNA, Stool",
author = "Daniele Calistri and Claudia Rengucci and Chiara Molinari and Enrico Ricci and Elena Cavargini and Emanuela Scarpi and Milandri, {Gian Luigi} and Carla Fabbri and Alberto Ravaioli and Antonio Russo and Dino Amadori and Rosella Silvestrini",
year = "2009",
doi = "10.3233/CLO-2009-0443",
language = "English",
volume = "31",
pages = "11--17",
journal = "Cellular oncology (Dordrecht)",
issn = "2211-3428",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - Quantitative fluorescence determination of long-fragment DNA in stool as a marker for the early detection of colorectal cancer

AU - Calistri, Daniele

AU - Rengucci, Claudia

AU - Molinari, Chiara

AU - Ricci, Enrico

AU - Cavargini, Elena

AU - Scarpi, Emanuela

AU - Milandri, Gian Luigi

AU - Fabbri, Carla

AU - Ravaioli, Alberto

AU - Russo, Antonio

AU - Amadori, Dino

AU - Silvestrini, Rosella

PY - 2009

Y1 - 2009

N2 - Background: A variety of molecular markers have been evaluated for the development of a non-invasive approach to the diagnosis of colorectal cancer. We aimed to validate the diagnostic accuracy, using the same threshold as in the previous pilot study, of fluorescent long DNA test as a relatively simple and inexpensive tool for colorectal cancer detection. Methods: A case-control study was conducted on 100 healthy subjects and 100 patients at first diagnosis of colorectal cancer. Human long-fragment DNA in stool was quantified by fluorescence primers and a standard curve and expressed in DNA nanograms. Results: We validated the 25-ng value, which emerged as the most accurate cut-off in the pilot study, obtaining 79% (95% CI, 71-87%) sensitivity and 89% (95% CI, 83-95%) specificity. Specificity was very high for all cut-off values (15-40 ng) analyzed, ranging from 78 to 96%. Sensitivity was only slightly lower, reaching 84% at the lowest cut-off and maintaining a good level at the higher values. Diagnostic potential was independent of gender, age and tumor site. Conclusion: Fecal DNA analysis is a non-invasive and fairly simple test showing high diagnostic potential. These characteristics, together with the small amount of stool required, make it potentially suitable to be used alongside or as an alternative to current non-invasive screening approaches. Our next step will be to validate these results in a large-scale cohort study of a screening population, which is needed prior to implementation into clinical practice.

AB - Background: A variety of molecular markers have been evaluated for the development of a non-invasive approach to the diagnosis of colorectal cancer. We aimed to validate the diagnostic accuracy, using the same threshold as in the previous pilot study, of fluorescent long DNA test as a relatively simple and inexpensive tool for colorectal cancer detection. Methods: A case-control study was conducted on 100 healthy subjects and 100 patients at first diagnosis of colorectal cancer. Human long-fragment DNA in stool was quantified by fluorescence primers and a standard curve and expressed in DNA nanograms. Results: We validated the 25-ng value, which emerged as the most accurate cut-off in the pilot study, obtaining 79% (95% CI, 71-87%) sensitivity and 89% (95% CI, 83-95%) specificity. Specificity was very high for all cut-off values (15-40 ng) analyzed, ranging from 78 to 96%. Sensitivity was only slightly lower, reaching 84% at the lowest cut-off and maintaining a good level at the higher values. Diagnostic potential was independent of gender, age and tumor site. Conclusion: Fecal DNA analysis is a non-invasive and fairly simple test showing high diagnostic potential. These characteristics, together with the small amount of stool required, make it potentially suitable to be used alongside or as an alternative to current non-invasive screening approaches. Our next step will be to validate these results in a large-scale cohort study of a screening population, which is needed prior to implementation into clinical practice.

KW - Colorectal cancer

KW - Diagnosis

KW - Fluorescence long DNA

KW - Stool

UR - http://www.scopus.com/inward/record.url?scp=58149380020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149380020&partnerID=8YFLogxK

U2 - 10.3233/CLO-2009-0443

DO - 10.3233/CLO-2009-0443

M3 - Article

C2 - 19096146

AN - SCOPUS:58149380020

VL - 31

SP - 11

EP - 17

JO - Cellular oncology (Dordrecht)

JF - Cellular oncology (Dordrecht)

SN - 2211-3428

IS - 1

ER -